Preoperative Corticosteroid Injections Within 4 Weeks of Arthroscopic Shoulder Procedures Are Associated With Increased Postoperative Infection Rates

Copyright © 2023 Arthroscopy Association of North America. Published by Elsevier Inc. All rights reserved..

PURPOSE: To refine the understanding of the effect of timing of corticosteroid injections (CSIs) and shoulder arthroscopy on postoperative infection.

METHODS: An insurance database was used to determine all patients who underwent shoulder arthroscopy for a 5-year period with an associated preoperative ipsilateral corticosteroid injection. Patients were stratified into cohorts based on timing of preoperative CSI: (1) 0-<2 weeks, (2) 2-<4 weeks, (3) 4-<6 weeks, and (4) 6-<8 weeks. Patients were pooled to include all patients who had a CSI less than 4 weeks and those longer than 4 weeks. A cohort of patients who never had a corticosteroid injection before undergoing arthroscopy were used as a control. All patients had a follow-up of 2 years. Multivariable regression analyses were performed using R Studio with significance defined as P < .05.

RESULTS: Multivariate logistic regression showed a greater odds ratio (OR) for postoperative infection in patients who received CSI 0-<2 weeks before shoulder arthroscopy at 90 days (3.10, 95% confidence interval [CI] 1.62-5.57, P < .001), 1 year (2.51, 95% CI 1.46-4.12, P < .001), and 2 years (2.08, 95% CI 1.27-3.28, P = .002) compared with the control group. Patients who received CSI 2-<4 weeks before shoulder arthroscopy had greater OR for infection at 90 days (2.26, 95% CI 1.28-3.83, P = .03), 1 year (1.82, 95% CI 1.13-2,82, P = .01), and 2 years (1.62, 95% CI 1.10-2.47, P = .012). Patients who received CSI after 4 weeks had similar ORs of infection at 90 days (OR 1.15, 95% CI 0.78-1.69, P = .48) 1 year (OR 1.18, 95% CI 0.85-1.63 P = .33), and 2 years (OR 1.09, 95% CI 0.83-1.42, P = .54), compared with the control cohort.

CONCLUSIONS: The present study shows the postoperative infection risk is greatest when CSIs are given within 2 weeks of shoulder arthroscopy, whereas CSIs given within 2-<4 weeks also portend increased risk, albeit to a lesser degree. The risk of postoperative infection is not significantly increased when CSIs are given more than 1 month before surgery.

LEVEL OF EVIDENCE: Level III, retrospective comparative, prognosis study.

Errataetall:

CommentIn: Arthroscopy. 2024 Feb;40(2):284-286. - PMID 38296435

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:40

Enthalten in:

Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association - 40(2024), 2 vom: 27. Feb., Seite 277-283.e1

Sprache:

Englisch

Beteiligte Personen:

Remily, Ethan [VerfasserIn]
Dubin, Jeremy [VerfasserIn]
Bains, Sandeep S [VerfasserIn]
Monarrez, Ruben [VerfasserIn]
Livesey, Michael G [VerfasserIn]
Weir, Tristan B [VerfasserIn]
Hameed, Daniel [VerfasserIn]
Ingari, John V [VerfasserIn]
Gilotra, Mohit N [VerfasserIn]
Hasan, S Ashfaq [VerfasserIn]

Links:

Volltext

Themen:

Adrenal Cortex Hormones
Journal Article

Anmerkungen:

Date Completed 02.02.2024

Date Revised 26.02.2024

published: Print-Electronic

CommentIn: Arthroscopy. 2024 Feb;40(2):284-286. - PMID 38296435

Citation Status MEDLINE

doi:

10.1016/j.arthro.2023.08.073

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM361866453